AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021
Feb 5, 2021
29864_dirs_2021-02-05_0b070e4e-7462-4120-b65a-797728d3ce36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-02-03
Reporting Person: LEIDEN JEFFREY M (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-03 | Common Stock | A | 31498 | $0.00 | Acquired | 33809 | Direct |
| 2021-02-03 | Common Stock | A | 31462 | $0.00 | Acquired | 65271 | Direct |
| 2021-02-03 | Common Stock | A | 20928 | $0.00 | Acquired | 86199 | Direct |
| 2021-02-03 | Common Stock | F | 8599 | $215.03 | Disposed | 77600 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 440 | Indirect |
Footnotes
F1: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021.
F2: Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/10/2021.
F3: Restricted stock unit award that fully vested upon grant.